Mersana Therapeutics
MRSN
MRSN
122 hedge funds and large institutions have $526M invested in Mersana Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 33 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.02% less ownership
Funds ownership: 3.9% → 3.87% (-0.02%)
11% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 37
84% less call options, than puts
Call options by funds: $366K | Put options by funds: $2.35M
Holders
122
Holding in Top 10
2
Calls
$366K
Puts
$2.35M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$13.1M | |
| 3 | +$11.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.86M |
| 5 |
JPMorgan Chase & Co
New York
|
+$6.04M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$23.9M | |
| 3 | -$15.5M | |
| 4 |
NI
Nextech Invest
Zurich,
Switzerland
|
-$9.51M |
| 5 |
Millennium Management
New York
|
-$8.45M |